ELDN
Eledon Pharmaceuticals Inc
NASDAQ: ELDN · HEALTHCARE · BIOTECHNOLOGY
$3.64
+8.98% today
Updated 2026-04-30
Market cap
$275.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $5
Volume
1.5M
Eledon Pharmaceuticals Inc (ELDN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-35.80%
ROA
-30.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-9.65M | — | — | — |
| 2013 | — | $-15.72M | — | — | — |
| 2014 | — | $-23.30M | — | — | — |
| 2015 | — | $-45.09M | — | — | — |
| 2016 | — | $-37.96M | — | — | — |
| 2017 | $0.00 | $-13.12M | — | — | — |
| 2018 | $0.00 | $-14.06M | — | — | — |
| 2019 | $0.00 | $-16.01M | — | — | — |
| 2020 | $120000.00 | $-22.81M | -152.50% | -11,069.17% | -19,009.17% |
| 2021 | $120000.00 | $-34.51M | 100.00% | -30,722.50% | -28,755.00% |
| 2022 | $0.00 | $-87.97M | — | — | — |
| 2023 | $0.00 | $-40.33M | — | — | — |
| 2024 | $0.00 | $-36.18M | — | — | — |
| 2025 | $0.00 | $-45.62M | — | — | — |